CoChat

Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer

Open access

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Significance: By culturing a human colorectal cancer (CRC) cell line (HCA-7) in 3D, we have generated two cell lines (CC and SC) with distinct morphological, genetic, biochemical, and functional properties. Using this 3D system, we have discovered that increased tyrosine phosphorylation of MET and RON results in cetuximab resistance in the SC cell line that can be overcome by addition of the dual MET/RON tyrosine kinase inhibitor, crizotinib. We have also identified that increased epithelial, but not stromal, versican staining correlates with reduced survival in a clinically annotated CRC tissue microarray.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1618297114

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 50

Metadata

Authors
Li, C., Singh, B., Graves-Deal, R., Ma, H., Starchenko, A., Fry, W. H., Lu, Y., Wang, Y., Bogatcheva, G., Khan, M. P., Milne, G. L., Zhao, S., Ayers, G. D., Li, N., Hu, H., Washington, M. K., Yeatman, T. J., McDonald, O. G., Liu, Q., & Coffey, R. J.
Affiliations
  • Xiamen University (CN)
  • Vanderbilt University (US)
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232;
  • Whitehead Institute for Biomedical Research (US)
  • Emory University (US)
  • Vanderbilt University Medical Center (US)
  • Peking Union Medical College Hospital (CN)
  • Gibbs Cancer Center & Research Institute, Spartanburg, SC 29303;
Venue
Proceedings of the National Academy of Sciences
Published
2017-03-20
Volume
114
Issue
14
Pages
E2852-E2861
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2597422592
Cited by
47
References
63
Citations by year
2026: 1 · 2025: 1 · 2024: 7 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 10 · 2019: 6 · 2018: 4 · 2017: 5
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
HHS | NIH | National Cancer Institute (RO1 CA 46413, P50 95103)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords
cetuximab resistance, colorectal cancer, 3D cell culture, versican, 15-hydroxyprostaglandin dehydrogenase, prognostic factors, xenografts, disease-associated genes, EGFR inhibitors
MeSH terms
Cetuximab, Antineoplastic Agents, Immunological, Receptor, Transforming Growth Factor-beta Type II, Crizotinib, Animals, Humans, Hydroxyprostaglandin Dehydrogenases, Phosphorylation, Pyrazoles, Pyridines, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Cell Culture Techniques, Drug Resistance, Neoplasm, Xenograft Model Antitumor Assays, Cell Line, Tumor, Tissue Array Analysis, Proto-Oncogene Proteins c-akt, Mice, Versicans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer. https://app.cochat.ai/papers/10.1073/pnas.1618297114
The paper
Li, C., Singh, B., Graves-Deal, R., Ma, H., Starchenko, A., Fry, W. H., Lu, Y., Wang, Y., Bogatcheva, G., Khan, M. P., Milne, G. L., Zhao, S., Ayers, G. D., Li, N., Hu, H., Washington, M. K., Yeatman, T. J., McDonald, O. G., Liu, Q., & Coffey, R. J. (2017). Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1618297114

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.